Multiple Sclerosis
Conference Coverage
Paramagnetic Rim Lesions Gain Traction as Prognostic Biomarker in MS
Paramagnetic rim lesions (PRLs) predict cognitive impairment among other signs of aggressive multiple sclerosis.
Article
Improved Communication Center Stage in Multiple Sclerosis
In this Care Cues, a neurologist and a stand-up comic with multiple sclerosis share thoughts on improving communication between clinicians and...
From the Journals
Autoimmune Disease Risk May Rise Following Cushing Disease Remission After Surgery
The findings suggested the need for closer postsurgical monitoring of patients with a family history of autoimmune disease.
From the Journals
Comorbidities and Disease Type Weigh Heavily in Pregnancy Outcomes of Immune-Mediated Inflammatory Diseases
After controlling for other chronic conditions, certain immune-mediated inflammatory diseases were not associated with an increased risk for poor...
From the Journals
New Findings on Vitamin D, Omega-3 Supplements for Preventing Autoimmune Diseases
Omega-3 fatty acid supplements prevented autoimmune diseases for 2 years after cessation, but vitamin D’s effects tapered off, suggesting that...
From the Journals
Autoimmune Diseases and Perinatal Depression May Share Two-Way Link
Study found women with autoimmune disease were 30% more likely to have perinatal depression. Risk was also 30% higher for the reverse scenario.
Literature Review
Depression, constipation, UTIs early signs of MS?
“The main contribution of the data on prodromes in MS is to clarify that the disease and its mechanisms are frequently underway well before the...
Literature Review
Blood test could predict future disability in MS
“This rising of NfL up to 2 years before signs of disability worsening represents the window when interventions may prevent worsening.”
Conference Coverage
Artificial intelligence presents opportunities, challenges in neurologic practice
Programs can generate health care and research content, but require close supervision and an attitude of ‘trust, but verify.’
Conference Coverage
Subcutaneous ocrelizumab, ofatumumab ‘reassuring’ in MS
The study “makes me feel pretty comfortable that regardless of where you’re delivering the therapy, IV or subcutaneously, it’s getting in there...
Conference Coverage
‘Frame running’ may help boost physical activity in MS
‘Frame running’ uses a three-wheeled frame with a saddle and body supports but no pedals to allow individuals with disabilities and balance...